UBS Group AG - AZURRX BIOPHARMA INC ownership

AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 17 filers reported holding AZURRX BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AZURRX BIOPHARMA INC
ValueSharesWeighting
Q2 2021$10,000
+100.0%
12,554
+271.9%
0.00%
Q1 2021$5,000
+400.0%
3,376
+136.9%
0.00%
Q1 2020$1,000
-75.0%
1,425
-41.7%
0.00%
Q2 2019$4,000
-66.7%
2,443
-74.9%
0.00%
Q4 2018$12,000
-20.0%
9,724
+68.1%
0.00%
Q3 2018$15,000
+50.0%
5,786
+94.7%
0.00%
Q2 2018$10,000
+42.9%
2,971
+63.4%
0.00%
Q4 2017$7,000
-41.7%
1,818
-41.0%
0.00%
Q3 2017$12,000
+9.1%
3,080
+11.2%
0.00%
Q2 2017$11,000
-8.3%
2,769
-9.1%
0.00%
Q1 2017$12,000
+300.0%
3,046
+393.7%
0.00%
Q4 2016$3,0006170.00%
Other shareholders
AZURRX BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Pensionmark Financial Group, LLC 80,000$57,0000.02%
PARSONS CAPITAL MANAGEMENT INC/RI 178,203$127,0000.01%
Traynor Capital Management, Inc. 24,999$20,0000.01%
ARDSLEY ADVISORY PARTNERS LP 30,000$21,0000.00%
Waldron Private Wealth LLC 69,835$49,0000.00%
Beacon Pointe Advisors, LLC 39,363$28,0000.00%
Patriot Financial Group Insurance Agency, LLC 6,250$4,0000.00%
BlackRock Inc. 15,338$11,0000.00%
Bank of New York Mellon Corp 215,313$153,0000.00%
Plante Moran Financial Advisors, LLC 800$1,0000.00%
View complete list of AZURRX BIOPHARMA INC shareholders